
https://www.facingourrisk.org/research-clinical-trials/study/396 /genetic-testing-for-cancer-risk-for-black-families-in-texas
Clinicaltrials.gov identifier:
NCT05694559 (https://clinicaltrials.gov/show/NCT05694559)
Prevention
Study to improve genetic counseling and testing to Black families in Texas
Study Contact Information:
For additional information, please contact:
Name: Banu Arun, MD
Phone Number: 713-792-2817
Email: [email protected]
This research study is looking at ways to improve access to hereditary cancer genetic counseling and genetic testing for Black families in the Houston, Texas area. People who qualify can choose to have genetic counseling (in person or by video/phone) and genetic testing. If results show a mutation or an uncertain result, participants can be connected to a genetic counselor and receive information to help family members consider testing.
At least one adult from each family may take part. Family members may also be invited to consider testing, depending on results.
You will complete a short screening form about your personal and family history of cancer.
If the screening form shows you may be eligible for hereditary cancer genetic testing, the study team will contact you to review your results and offer genetic counseling. Counseling may be done in person or by telehealth (video or phone).
If you decide to have genetic testing, you will receive a saliva collection kit (spit sample). You do not need to have blood drawn for this test.
If your results show an inherited mutation or an uncertain result (also called a “variant of unknown significance”), you may be connected with a genetic counselor. The study team may also share information and resources to help your relatives learn about genetic testing.
This study is open to people ages 18 and older who identify as Black or African American.
This study is not open to people who are not Black or African American.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.